EMA — authorised 2 August 2019
- Marketing authorisation holder: Celgene Europe BV
- Status: approved
🇪🇺 Vidaza in European Union
EMA authorised Vidaza on 2 August 2019
Marketing authorisation
Vidaza in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Vidaza approved in European Union?
Yes. EMA authorised it on 2 August 2019.
Who is the marketing authorisation holder for Vidaza in European Union?
Celgene Europe BV holds the EU marketing authorisation.